Clinical Trial Update: Effect of Carnosine on Diabetes and Cardiovascular Risk Factors [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of carnosine on Type 2 diabetes and related cardiovascular risk factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Carnosine (carnosine)

Snippet

Sponsor: Jozef Ukropec | Conditions: Metabolic Diseases, Type 2 Diabetes, Cardiovascular Disease | NA | Status: COMPLETED